Biogen Idec shares owned by Vantage Consulting Group
Quarter-by-quarter ownership of Biogen Idec (BIIB) shares owned by Vantage Consulting Group
from 13F filings
Historical chart of Vantage Consulting Group investment in Biogen Idec
Tip: Access up to 7 years of quarterly data
All positions including Biogen Idec held by Vantage Consulting Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Biogen Idec by Vantage Consulting Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $253k | 979 | 258.77 |
| 2023-09-30 | $231k | 899 | 257.01 |
| 2023-06-30 | $211k | 742 | 284.85 |
| 2023-03-31 | $260k | 935 | 278.03 |
| 2022-12-31 | $234k | 846 | 276.92 |
| 2022-09-30 | $323k | 1.2k | 267.38 |
| 2022-06-30 | $248k | 1.2k | 203.61 |
| 2022-03-31 | $244k | 1.2k | 210.34 |
| 2021-12-31 | $268k | 1.1k | 239.71 |
| 2021-09-30 | $230k | 813 | 282.90 |
| 2021-06-30 | $200k | 578 | 346.02 |
| 2020-12-31 | $74k | 303 | 244.22 |